Dr. Frederick Beddingfield, left, CEO of Sienna Biopharmaceuticals, and Bob More, managing director at venture capital firm Alta Partners, speak at a BioScience Alliance event in May 2016. A recent IPO filing by a biotech company in the Conejo Valley showed that the region is beginning, albeit slowly, to diversify beyond pharmaceutical giant Amgen. Westlake…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
